Ahmed Bennis MD 🫀

Cardiovascular Risk, Health Metrics, and Cancer Prediction: A Scoping Review Despite heterogeneity in CVD risk metrics and cancer types, most studies suggested that worse CVD risk scores or CVH metrics predict greater cancer risk jacc.org/doi/10.1016/j.…

Primary Left Atrial Cardiopathy in Transthyretin Amyloidosis Cardiomyopathy by Multimodality Imaging: Implications for Thrombotic Events Primary LA cardiopathy seems to be associated with TEs in ATTR-CM, independently of AF, CHA2DS2-VASc, and LA dilatation, unlike other LVH…

AI-Enabled Smartwatch ECG: A Feasibility Study for Early Prediction and Prevention of Heart Failure Rehospitalization This study integrates AI-ECG with smartwatch-based daily monitoring, offering a noninvasive and cost-effective solution for predicting HF exacerbations…

Artificial Intelligence for Cardiovascular Care AI models can detect cardiovascular disorders including reduced ejection fraction, valvular heart disease, and cardiomyopathies from electrocardiograms with accuracy not previously achieved by human experts or technology All…

Automated Detection of Reduced Ejection Fraction Using an ECG-Enabled Digital Stethoscope: A Large Cohort Validation The CNN model, utilizing a digital stethoscope, offers a noninvasive and scalable method for early detection of individuals with EF ≤40% #SciComm,…

HEART FAILURE RISK PREDICTION USING ARTIFICIAL INTELLIGENCE ON ECG PHOTOS IN LARGE CONTEMPORARY COHORT An AI model applied to a single 12-lead ECG photo can enable scalable & efficient HF screening by serving as a digital biomarker for HF prediction #cardiotwitter #CardioX #AI…

Artificial Intelligence-Enabled Electrocardiogram Model for Predicting Heart Failure with Preserved Ejection Fraction– A Single-Center Study The AI-ECG model is a reliable tool for predicting HFpEF, as defined by the HFA-PEFF score, and effectively stratifies patients according…

GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction GLP-1RA use is associated with improved cardiovascular outcomes in nonobese patients with T2DM and HFpEF and has an associated incremental benefit even…

Heart failure improvement, remission, and recovery: A European Journal of Heart Failureexpert consensus document This expert consensus document delineates HF trajectories, examines factors reflecting HF improvement beyond recovery of LVEF, and explores the prognostic…

Clinical and Engagement Results of a Nationwide Comprehensive Remote Patient Care Hypertension Program A nationwide RPC hypertension program can drive high patient engagement and facilitate clinical encounters at scale, resulting in reduced BP levels and more patients achieving…

Modeling potential cost-effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity The model predicted that all doses of tirzepatide represent cost-effective alternatives to LSM for management of overweight and obesity at a…

Residual pulmonary hypertension and clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fraction The prognostic importance of residual PH was comparable across both HF with reduced and preserved ejection fraction patients…

Prognostic impact of frailty at admission and in-hospital changes of frailty status in elderly patients with acute heart failure Frailty is an independent prognostic marker of increased mortality risk in patients with AHF. Improvement of frailty status during hospitalization…

Pharmacological Therapy of HFrEF in 2025: Navigating New Advances and Old Unmet Needs in An Eternal Balance Between Progress and Perplexities The established four pillars of HFrEF treatment – β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor–…

Single versus Dual Antiplatelet Therapy in Patients with Severe Peripheral Arterial Disease Undergoing TAVI: Insights from The Hostile Registry In TAVI patients with severe PAD, DAPT was associated with a trend toward improved outcomes compared with SAPT, particularly in those…

Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort Study These findings support the residual risk associated with incompletely controlled LDL-C or non-HDL-C levels after statin initiation for primary prevention…

Artificial Intelligence-Enabled Electrocardiogram Model for Predicting Heart Failure with Preserved Ejection Fraction– A Single-Center Study The AI-ECG model is a reliable tool for predicting HFpEF, as defined by the HFA-PEFF score, and effectively stratifies patients according…

Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study In this nationwide study, MV replacement was associated with a 3.5-fold increased 10-year IE rate, whereas MV repair was not significantly associated with IE, compared…

Long-Term Outcomes of BAV-0 Patients Compared With BAV-1 and TAV Patients After TAVR Among patients with severe AS undergoing TAVR, BAV-0 was associated with a better long-term prognosis compared with TAV and BAV-1 jacc.org/doi/10.1016/j.…

Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial Tirzepatide consistently reduced the risk of HF or cardiovascular death regardless of baseline BMI, but there was evidence suggesting greater improvement in…